首页> 美国卫生研究院文献>other >Application of Surgical Apgar Score in intracranial meningioma surgery
【2h】

Application of Surgical Apgar Score in intracranial meningioma surgery

机译:Apgar评分在颅内脑膜瘤手术中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Surgical resection is the main therapeutic option for intracranial meningiomas, but it is not without significant morbidities. The Surgical Apgar Score (SAS), assessed by intraoperative blood pressure, heart rate, and blood loss, was developed for prognostic prediction in general and vascular surgery. We aimed to examine whether the application of SAS in patients undergoing craniotomy for meningioma resection can predict postoperative major complications. We retrospectively enrolled 99 patients that had undergone intracranial meningioma surgery. The patients were subdivided into 2 groups based on whether major complications were present (N = 34) or not (N = 65). We recognized the intergroup differences in SAS and clinical variables. The incidence of 30-day major complications in patients after operation was 34.3%. The lengths of ICU and hospital stay for the morbid cases were prolonged significantly (p = 0.009, p < 0.001, respectively). In the multivariate logistic regression model, SAS was an independent predicting factor of major complications following surgery for intracranial meningiomas (odds ratio, 95% confidence interval = 0.57, 0.38–0.87; p = 0.009), and thus a decrease of one mean SAS increased the rate of major complications by 43%. In conclusions, SAS is an independent predictor of major complications in patients undergoing intracranial meningioma surgery, and provides acceptable risk discrimination. Since this scoring system is relatively simple, objective, and practical, we suggest that SAS be included as an indicator in the guidance for the level of care after craniotomy for meningioma resection.
机译:手术切除是颅内脑膜瘤的主要治疗选择,但并非没有明显的发病率。通过术中血压,心率和失血评估的手术Apgar评分(SAS)用于一般和血管外科手术的预后预测。我们旨在检查在开颅手术切除脑膜瘤患者中使用SAS是否可以预测术后的重大并发症。我们回顾性研究了接受颅内脑膜瘤手术的99例患者。根据是否存在重大并发症(N = 34)(N = 65)将患者分为两组。我们认识到SAS和临床变量的组间差异。术后30天主要并发症的发生率为34.3%。病态病例的ICU和住院时间显着延长(分别为p = 0.009,p <0.001)。在多因素logistic回归模型中,SAS是颅内脑膜瘤手术后主要并发症的独立预测因素(几率,95%置信区间= 0.57、0.38–0.87; p = 0.009),因此平均SAS降低了1个重大并发症发生率降低了43%总之,SAS是颅内脑膜瘤手术患者主要并发症的独立预测指标,并提供可接受的风险区分。由于该评分系统相对简单,客观且实用,因此我们建议在开颅脑膜瘤切除手术后的护理水平指南中将SAS纳入指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号